RT Journal Article
SR Electronic
T1 High prevalence of an alpha variant lineage with a premature stop codon in ORF7a in Iraq, winter 2020-2021
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.20.21265042
DO 10.1101/2021.10.20.21265042
A1 Al-Rashedi, Nihad A.M
A1 Alburkat, Hussein
A1 Hadi, Abas O.
A1 Munahi, Murad G.
A1 Jasim, Ali
A1 Hameed, Alaa
A1 Oda, Basel Saber
A1 Lilo, Kareem Moamin
A1 AlObaidi, Laith A.H.
A1 Vapalahti, Olli
A1 Sironen, Tarja
A1 Smura, Teemu
YR 2021
UL http://medrxiv.org/content/early/2021/10/22/2021.10.20.21265042.abstract
AB Background Since the first reported case of coronavirus disease 2019 (COVID-19) in China, SARS-CoV-2 has been spreading worldwide. Genomic surveillance of SARS-CoV-2 has had a critical role in tracking the emergence, introduction, and spread of new variants, which may affect transmissibility, pathogenicity, and escape from infection or vaccine-induced immunity. As anticipated, the rapid increase in COVID-19 infections in Iraq in February 2021 is due to the introduction of variants of concern during the second wave of the COVID-19 pandemic.Aim To understand the molecular epidemiology of SARS-CoV-2 during the second wave in Iraq (2021),Method We sequenced 76 complete SARS-CoV-2 genomes using NGS technology and identified genomic mutations and proportions of circulating variants among these. Also, we performed an in silico study to predict the effect of the truncation of NS7a protein (ORF7a) on its functionResults We detected nine different lineages of SARS-CoV-2. The B.1.1.7 lineage was predominant (78.9%) from February to May 2021, while only one B.1.351 strain was detected. Interestingly, the phylogenetic analysis showed that multiple strains of the B.1.1.7 lineage clustered closely with those from European countries. A high frequency (88%) of stop codon mutation (NS7a Q62stop) was detected among the B.1.1.7 lineage sequences. In silico analysis of NS7a with Q62stop found that this stop codon had no significant effect on the function of NS7a.Conclusion This work provides molecular epidemiological insights into the spread variants of SARS-CoV-2 in Iraq, which are most likely imported from Europe.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Sawa University, Samawa, Iraq.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Al Muthanna University gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll raw sequencing data used in this study are available on the Sequence Read Archive (SRA) under the BioProject accession numbers PRJNA731979, PRJNA735311, and PRJNA738286. The genome sequences were deposited in GISAID and GenBank and are now accessible by the numbers listed in Supplementary Table S1 and S3.